Clinical Trials Browser

Terminated × Capecitabine × Endocrine × Clear all

NCT07012330 2025-06-10

Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Phase 2 Terminated

Neoplasms, Neuroendocrine Tumors

NCT03387592 2025-03-10

SENECA

Phase 2 Terminated

Carcinoma, Neuroendocrine

NCT02736448 2025-01-13

Lu-Ca-S

Phase 2 Terminated

EndocrineGastrointestinalNET

Gastro-entero-pancreatic Neuroendocrine Tumors